FDA Gives Nod To Medtronic's Hemodialysis Device For Pediatric Patients

The U.S. Food and Drug Administration granted marketing authorization to Medtronic Inc.'s CARPEDIEM System, a new device for continuous dialysis therapy for use in pediatric patients with certain kidney conditions. The system is indicated to provide continuous hemodialysis or hemofiltration therapy to critically ill pediatric patients weighing between 2.5 and 10 kilograms.

from RTT - Biotech https://ift.tt/2So9VkS
via IFTTT